TUPEA11 | DPP9 inhibitors: a novel class of drugs for clearance of HIV-1 infected cells | Poster exhibition | Novel treatment and prevention strategies |
OAE0103 | Drivers of pre-exposure prophylaxis choice for transgender women in 11 countries in Asia: a discrete choice experiment | Oral abstract session with live Q&A | Implementation science and scale up of prevention |
EPB0153 | Drug Resistant Tuberculosis (DR-TB) detection among new, previously treated TB cases, and people living with HIV in Western and Southern highlands, Tanzania | E-poster | Co-infections (including opportunistic infections) |
OAC0404 | Drug-drug interaction between emtricitabine/tenofovir alafenamide (FTC/TAF)-based PrEP and feminizing hormones in transgender women: peripheral blood mononuclear cells and urine analysis from the iFACT3 study | Oral abstract session with live Q&A | HIV prevention research |
EPA0085 | Dual therapy of Interleukin-21 and anti-α4β7 antibody administration during ART-treated SIV promotes immunological responses and ameliorates dysbiosis in rhesus macaques | E-poster | Novel treatment and prevention strategies |
EPA0038 | Duration of antiretroviral therapy is a determinant of the frequency of NKG2C+CD57+ adaptive NK cells in persons living with cytomegalovirus and HIV infections | E-poster | Host immune responses, vaccines and immunotherapies |
EPD0585 | Dynamic partnership to redefine community engagement in HIV programming in Nigeria | E-poster | Social and behavioural aspects and approaches to HIV |
EPB0136 | Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV | E-poster | Co-infections (including opportunistic infections) |
EPA0012 | Dysregulated transcriptional signature of Th17-Polarized cells during chronic HIV Infection despite successful antiretroviral therapy compared to uninfected individuals | E-poster | HIV pathogenesis |
EPB0249 | Early ART and mental health outcomes by school-age and adolescent years of life: a longitudinal comparative study of HIV-exposed and community control adolescents from Uganda | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |